Showing results (2391-2400 of 2,937) with videos related to

Sort By:
Pageof 294
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 18, 2010
[Study on the prevalence of metabolic syndrome among the Kazakh population in Xinjiang]Heng Guo, Shu-xia Guo, Jing-yu Zhang, et al.
Frontiers in Cell and Developmental Biology|August 19, 2021
MiR-302a Limits Vascular Inflammation by Suppressing Nuclear Factor-κ B Pathway in Endothelial CellsJia-Ni Yuan, Yu Hong, Zhuo-Lin Ma, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|May 1, 2019
[Correlation of K-ras Gene Mutations with the Protein Expressions of TAK1 and MAP4K2 in Colorectal Cancer]Qi-Zhao Ma, Yi-Wen Yang, Yan-Lin Ma, et al.
Radiation Protection Dosimetry|December 12, 2018
A HYPOTHESIS OF RADIORESISTANCE AND CELL-SURVIVAL CURVE SHAPE BASED ON CELL-CYCLE PROGRESSION AND DAMAGE TOLERANCECarsten Herskind, Qi Liu, Xiaolei Liu, et al.
Breast Cancer Research and Treatment|August 10, 2017
Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormonesYiwey Shieh, Donglei Hu, Lin Ma, et al.
Mechanisms of Ageing and Development|December 18, 2017
Atorvastatin exerts inhibitory effect on endothelial senescence in hyperlipidemic rats through a mechanism involving down-regulation of miR-21-5p/203a-3pJie-Jie Zhang, Yin-Zhuang Zhang, Jing-Jie Peng, et al.
Biomedical and Environmental Sciences : BES|October 30, 2018
The Bidirectional Effects of Arsenic on miRNA-21: A Systematic Review and Meta-analysisJia Qing Liu, Qing Niu, Yun Hua Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 17, 2019
Neuroprotective effect of Vanillin on hypoxic-ischemic brain damage in neonatal ratsXiao-Bing Lan, Qing Wang, Jia-Mei Yang, et al.
Optics Letters|September 14, 2018
Experimental demonstration of a few-mode Raman amplifier with a flat gain covering 1530-1605 nmJiaxiong Li, Lulu Wang, Jiangbing Du, et al.
Acta Pharmacologica Sinica|March 21, 2025
Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathwayJia-Wen Xu, Lin Ma, Yu Xiang, et al.
Pageof 294